Denosumab Drug Substance from Mexico

Denosumab is RANKL inhibitor monoclonal antibody for osteoporosis and cancer bone metastases. HTS 3002.13.0090 unmixed immunological product. Bulk biotech supply.

Duty Rate — Mexico → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter

Import Tips

Bone metabolism marker correlation data

Refrigerated bill of lading mandatory

No retail intent declaration